Phase I/II Study of the Tumor-targeting Human L19TNF Monoclonal Antibody-cytokine Fusion Protein in Patients With Advanced Solid Tumors
Phase of Trial: Phase I/II
Latest Information Update: 21 Nov 2015
At a glance
- Drugs L19 TNF fusion protein (Primary)
- Indications Colorectal cancer; Solid tumours
- Focus Adverse reactions; Therapeutic Use
- Sponsors Philogen
- 22 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Sep 2011 Actual end date (Sep 2011) added as reported by ClinicalTrials.gov.
- 29 Apr 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.